GGrantIndex
Sort

8,912 grants matching sars cov 2

Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy

$725,288
Pamela Tinmoi Wong · University Of Michigan At Ann Arbor · R01 · FY2023 · AI

Mitigating Adverse Effects of COVID-19 through Preventive Interventions for Families with Young Children Living in Poverty: Linking Data from 3 Cities with Diverse Risks and Exposures

$725,146
Alan L Mendelsohn · New York University School Of Medicine · R01 · FY2022 · HD

Research Employing Environmental Systems and Occupational Health Policy Analyses to Interrupt the Impact of Structural Racism on Agricultural Workers and Their Respiratory Health (RESPIRAR)

$725,116
Devon C Payne-Sturges · Univ Of Maryland, College Park · R01 · FY2024 · ES

EpiMoRPH: A simulation environment for generating spatially-refined intervention strategies for the control of infectious disease

$724,855
Joseph Mihaljevic · Northern Arizona University · R01 · FY2022 · AI

Cognitive sequelae of cerebrovascular and gut dysfunction in post-acute COVID-19 syndrome.

$724,725
Andrei A Vakhtin · Lovelace Biomedical Research Institute · R01 · FY2025 · NS

Intensifying Community Referrals for Health: The SINCERE Intervention to Address COVID-19 Health Disparities

$724,311
Andrea Schneider Wallace · University Of Utah · R01 · FY2023 · NR

Mechanisms and Treatment of SARS-CoV-2 induced Lung Endothelial Injury

$724,225
Jalees Rehman · University Of Illinois At Chicago · R01 · FY2024 · HL

The longer-term impact of prenatal exposure to SARS-CoV-2 infection and the COVID-19 vaccine on behavior, cognition, and brain functioning in the child

$723,710
Anna-Sophie Rommel · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · HD

Immunological drivers of the transition from epidemicity to endemicity of SARS-CoV-2 in a high transmission LMIC setting

$723,680
Albert Icksang Ko · Yale University · R01 · FY2025 · AI

De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics

$723,634
David Baker · University Of Washington · R01 · FY2021 · AI

A 3D IN VITRO DISEASE MODEL OF ATRIAL CONDUCTION

$723,616
Steven Carl George · University Of California At Davis · UH3 · FY2020 · HL

mRNA-encoded Cas13 as a pan-respiratory antiviral

$723,501
Philip J Santangelo · Emory University · R01 · FY2023 · AI

Community-based Design and Evaluation of a Conversational Agent to Promote SARS-COV2 Vaccination in Black Churches

$723,305
Timothy W Bickmore · Northeastern University · R01 · FY2022 · MD

Proteomics-Driven Reverse Vaccinology for Gonorrhea

$723,264
Aleksandra Elzbieta Sikora · Oregon State University · R01 · FY2025 · AI

Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19

$723,154
Alexander Misharin · Northwestern University At Chicago · R01 · FY2025 · HL

Structural vaccinology for infectious diseases

$723,116
Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2

$722,958
Anne Moscona · Columbia University Health Sciences · R01 · FY2022 · AI

Elucidating the immunology of autoantibody formation and function in COVID-19

$722,919
Angela J Rogers · Stanford University · R01 · FY2025 · AI

Pre-Existing Atopy and Respiratory Viral Infections

$722,806
Mitchell H Grayson · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · AI

Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines

$722,737
Luis J. Sigal · Thomas Jefferson University · R01 · FY2023 · AI

ECMO without Anticoagulation

$722,686
Alvaro Rojas-Pena · University Of Michigan At Ann Arbor · R01 · FY2024 · HL

Maternal SARS-CoV-2 infection, placenta biology, and neurodevelopmental outcomes in the offspring

$722,608
Gianluca Ursini · Lieber Institute, Inc. · R01 · FY2023 · HD

Marshallese: Alternate Surveillance for COVID-19 in a Unique Population

$722,487
Ka'imi Alohilani Sinclair · Washington State University · R01 · FY2021 · MD

Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in blood

$722,477
Zhen Huang · Tulane University Of Louisiana · R01 · FY2025 · AI

Development of pan-betacoronavirus vaccines

$722,284
Raiees Ahmad Andrabi · University Of Pennsylvania · R01 · FY2024 · AI